---
title: "Denileukin diftitox - Primary cutaneous t-cell lymphoma"
sidebar: mydoc_sidebar
permalink: db00004-mesh-d016410-1.html
toc: false 
---


Path ID: `DB00004_MESH_D016410_1`
{% include image.html url="images/db00004-mesh-d016410-1.png" file="db00004-mesh-d016410-1.png" alt="db00004-mesh-d016410-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C078456 | denileukin diftitox | Drug |
| UniProt:P01589 | Interleukin-2 receptor subunit alpha | Protein |
| UniProt:P14784 | Interleukin-2 receptor subunit beta | Protein |
| UniProt:P31785 | Cytokine receptor common subunit gamma | Protein |
| GO:0006898 | receptor-mediated endocytosis | BiologicalProcess |
| GO:1901998 | toxin transport | BiologicalProcess |
| MESH:D004167 | Diphtheria Toxin | ChemicalSubstance |
| UniProt:P13639 | Elongation factor 2 | Protein |
| GO:0006414 | translational elongation | BiologicalProcess |
| MESH:D016410 | Primary cutaneous T-cell lymphoma | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Denileukin Diftitox | MOLECULARLY INTERACTS WITH | Interleukin-2 Receptor Subunit Alpha |
| Denileukin Diftitox | MOLECULARLY INTERACTS WITH | Interleukin-2 Receptor Subunit Beta |
| Denileukin Diftitox | MOLECULARLY INTERACTS WITH | Cytokine Receptor Common Subunit Gamma |
| Interleukin-2 Receptor Subunit Alpha | PARTICIPATES IN | Receptor-Mediated Endocytosis |
| Interleukin-2 Receptor Subunit Beta | PARTICIPATES IN | Receptor-Mediated Endocytosis |
| Cytokine Receptor Common Subunit Gamma | PARTICIPATES IN | Receptor-Mediated Endocytosis |
| Receptor-Mediated Endocytosis | POSITIVELY CORRELATED WITH | Toxin Transport |
| Toxin Transport | INCREASES ABUNDANCE OF | Diphtheria Toxin |
| Diphtheria Toxin | DECREASES ACTIVITY OF | Elongation Factor 2 |
| Elongation Factor 2 | POSITIVELY REGULATES | Translational Elongation |
| Translational Elongation | CORRELATED WITH | Primary Cutaneous T-Cell Lymphoma |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB00004#mechanism-of-action](https://go.drugbank.com/drugs/DB00004#mechanism-of-action)
  - [https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201550/](https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201550/)
  - [https://en.wikipedia.org/wiki/Denileukin_diftitox](https://en.wikipedia.org/wiki/Denileukin_diftitox)
  - [https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/103767s5144lbl.pdf](https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/103767s5144lbl.pdf)
